Table 1 Baseline characteristics
AABO group (n = 34) | UAE group (n = 34) | P | |
|---|---|---|---|
Age, n (%) | |||
< 35 years | 19 (55.9) | 23 (67.6) | 0.318 |
≥ 35 years | 15 (44.1) | 11 (32.4) | |
Gestational age (weeks) | 7.3 (6.5, 9.4) | 7.3 (6.3, 8.0) | 0.332 |
Body mass index (kg/m2) | 24.0 (22.1, 26.8) | 24.1 (22.2, 25.5) | 0.695 |
Gravidity*, n (%) | 0.808 | ||
≤ 4 | 19 (55.9) | 18 (52.9) | |
> 4 | 15 (44.1) | 16 (47.1) | |
Parity, n (%) | 0.595 | ||
1 | 11 (32.4) | 9 (26.5) | |
> 1 | 23 (67.6) | 25 (73.5) | |
Prior cesarean section, n (%) | 1.000 | ||
1 | 14 (41.2) | 14 (41.2) | |
> 1 | 20 (58.8) | 20 (58.8) | |
Time interval from previous cesarean section (m) | 36.6 (30, 52.2) | 38.4 (27.6, 55.2) | 0.749 |
β-HCG before treatment (mIU/mL) | 35,805 (19760.5, 69831.5) | 34,175 (12,320, 61,221) | 0.806 |
Gestational sac diameter (mm) | 24.5 (20.0, 26.0) | 24.0 (20.0, 25.0) | 0.492 |
Embryonic bud length (mm) | 10.0 (9.0, 12.0) | 10.0 (9.0, 12.0) | 0.533 |
Embryonic heartbeat, n (%) | |||
Yes | 34 (100) | 34 (100) | / |